News Snapshot:
A total of 60,000 volunteers have received Chinese COVID-19 vaccines during phase-3 clinical trials, and no severe side effects have been reported, a Chinese official said on Tuesday. Four Chinese vaccine candidates have entered international phase-3 clinical trials. They are so far progressing well and have initially proven safe, said Tian Baoguo with the Ministry of Science and Technology at a news conference in Beijing. Also, China has signed up to a deal to ensure future COVID-19 vaccines are distributed to developing countries, the biggest economy yet to join the World Health Organisation-led bid to control the pandemic. The COVAX...
